COMP <GO>
BTSG vs JNJ // RSI-14 & 200D SMA MOMENTUM
BrightSpring Health Services Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BTSG 4
— JNJ 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BTSG
LAST: $66.89 (+11.08%) • MKT CAP: $11.92B
rsi-technicals
67.3
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
rsi-technicals
60.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTSG VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BTSG | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.80% | 67.90% | -56.10 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.50% | 25.50% | -20.00 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.9x | 18.5x | +19.40 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 3.31% | 2.97% | +0.34 | BTSG | /fcf-yield <GO> |
| Operating Margin | 2.30% | 34.70% | -32.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 28.50% | -27.00 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 28.20% | 6.00% | +22.20 | BTSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.92 | 5.59 | -1.67 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.20% | -0.50 | BTSG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 67.3 | 60.4 | +6.91 | BTSG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.08 | -0.14 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 52.9x | 23.0x | +29.90 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.92B | $662.49B | -$650.58B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BTSG REV | JNJ REV | BTSG GROSS % | JNJ GROSS % | BTSG FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.91B | $94.19B | 11.8% | 67.9% | $394.7M | $19.70B |
| FY 2024 | $10.07B | $88.82B | 12.6% | 69.1% | -$57.1M | $19.84B |
| FY 2023 | $7.69B | $85.16B | 44.0% | 44.0% | -$135.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BTSG // BETA 0.94
JNJ // BETA 1.08